Triple
T839865
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Phillip A. Sharp |
E18151
|
entity |
| Predicate | coFounded |
P104
|
FINISHED |
| Object |
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company specializing in the development of RNA interference (RNAi)-based therapeutics for genetically defined diseases.
|
E100609
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69a49389f44881909a608fb27d89f247 |
elicitation | completed |
| NER | batch_69a4abe4ab1081909207ae2eec1898d9 |
ner | completed |
| NED1 | batch_69a7929860f081909c86f84d7cfe6acb |
ned_source_triple | completed |
| NED2 | batch_69a796bee5388190ab0abf0bfa08ad97 |
ned_description | completed |
| NEDg | batch_69a796370f388190b23cd19cc3fa5a3b |
nedg | completed |
Created at: March 1, 2026, 7:38 p.m.